AI assistant
ABEONA THERAPEUTICS INC. — Director's Dealing 2025
Mar 31, 2025
33413_dirs_2025-03-31_86566c82-dfb2-4111-8ebe-04df98041ed7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABEONA THERAPEUTICS INC. (ABEO)
CIK: 0000318306
Period of Report: 2025-03-31
Reporting Person: Seshadri Vishwas (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-31 | Common Stock | S | 25000 | $4.78 | Disposed | 1355322 | Direct |
Footnotes
F1: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024.
F2: Weighted average price. These shares were sold in multiple transactions at prices ranging from $4.71 to $4.81 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.